Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Avidity Biosciences Inc (RNA)

Avidity Biosciences Inc (RNA)
24.11 x 2 24.15 x 59
Post-market by (Cboe BZX)
24.11 -0.69 (-2.78%) 04/10/25 [NASDAQ]
24.11 x 2 24.15 x 59
Post-market 24.11 unch (unch) 16:00 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
23.20
Day High
24.49
Open 23.89
Previous Close 24.80 24.80
Volume 1,743,344 1,743,344
Avg Vol 1,878,752 1,878,752
Stochastic %K 17.90% 17.90%
Weighted Alpha -35.70 -35.70
5-Day Change -3.99 (-14.20%) -3.99 (-14.20%)
52-Week Range 21.51 - 56.00 21.51 - 56.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,981,257
  • Shares Outstanding, K 120,212
  • Annual Sales, $ 10,900 K
  • Annual Income, $ -322,300 K
  • EBIT $ -379 M
  • EBITDA $ -398 M
  • 60-Month Beta 1.01
  • Price/Sales 265.64
  • Price/Cash Flow N/A
  • Price/Book 2.02

Options Overview Details

View History
  • Implied Volatility 109.94% ( +4.47%)
  • Historical Volatility 84.45%
  • IV Percentile 98%
  • IV Rank 83.47%
  • IV High 119.75% on 03/13/25
  • IV Low 60.36% on 08/19/24
  • Put/Call Vol Ratio 4.25
  • Today's Volume 21
  • Volume Avg (30-Day) 583
  • Put/Call OI Ratio 1.10
  • Today's Open Interest 15,276
  • Open Int (30-Day) 14,800

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.88
  • Number of Estimates 4
  • High Estimate -0.61
  • Low Estimate -1.05
  • Prior Year -0.79
  • Growth Rate Est. (year over year) -11.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.51 +12.09%
on 04/09/25
Period Open: 30.04
36.38 -33.73%
on 03/13/25
-5.93 (-19.74%)
since 03/10/25
3-Month
21.51 +12.09%
on 04/09/25
Period Open: 29.46
36.38 -33.73%
on 03/13/25
-5.35 (-18.16%)
since 01/10/25
52-Week
21.51 +12.09%
on 04/09/25
Period Open: 25.64
56.00 -56.95%
on 11/13/24
-1.53 (-5.97%)
since 04/10/24

Most Recent Stories

More News
Insider Sale: CSTO of $RNA (RNA) Sells 24,000 Shares

W. Michael Flanagan, the CSTO of $RNA ($RNA), sold 24,000 shares of the company on 12-11-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 21.9% of their shares....

RNA : 24.11 (-2.78%)
Insider Sale: Chief Human Resources Officer of $RNA (RNA) Sells 25,000 Shares

Teresa McCarthy, the Chief Human Resources Officer of $RNA ($RNA), sold 25,000 shares of the company on 11-18-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...

RNA : 24.11 (-2.78%)
Avidity Biosciences (RNA) Stock Surges on Positive AOC 1020 Trial Results

Avidity Biosciences (NASDAQ: RNA) has seen a significant surge in its stock price, opening nearly 5% higher today. This increase comes following impressive results from Avidity’s AOC 1020 clinical trial...

RNA : 24.11 (-2.78%)
2 Promising Growth Stocks to Buy and Hold for a Decade or Longer

These two growth stocks could be great additions to a long-term buy-and-hold portfolio.

RNA : 24.11 (-2.78%)
$SPX : 5,268.05 (-3.46%)
LLY : 720.91 (-4.35%)
UBER : 70.94 (-2.39%)
CART : 38.60 (-1.18%)
BMY : 50.46 (-6.10%)
Why Avidity Biosciences Zoomed to a 12% Gain This Week

The company's most promising pipeline program can continue unabated.

RNA : 24.11 (-2.78%)
GS : 489.80 (-5.24%)
Stocks Pressured by Middle East Risks

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.15%. Stocks today are...

NVDA : 107.57 (-5.91%)
CEG : 204.49 (-5.09%)
RNA : 24.11 (-2.78%)
$SPX : 5,268.05 (-3.46%)
ADI : 178.36 (-9.29%)
HIMS : 26.81 (-9.09%)
NXPI : 165.59 (-10.91%)
TSCO : 51.32 (-0.12%)
LUV : 25.79 (-9.67%)
ACN : 285.22 (-4.91%)
$IUXX : 18,343.57 (-4.19%)
STM : 18.93 (-12.36%)
2 Standout Biotech Stocks With 32% to 63% Upside

A strong pipeline of products could potentially transform these companies, but there are risks.

RNA : 24.11 (-2.78%)
$SPX : 5,268.05 (-3.46%)
BMY : 50.46 (-6.10%)
VRNA : 53.93 (-6.87%)
3 Russell 2000 Growth Stocks That Could Be Worth the Risk

These three small-cap stocks could deliver hefty returns if the central bank cuts rates.

LBPH : 59.98 (+0.03%)
RNA : 24.11 (-2.78%)
SOUN : 8.20 (-7.13%)
Avidity Biosciences (RNA) Stock Surges on Positive AOC 1020 Trial Results

Avidity Biosciences (NASDAQ: RNA) has seen a significant surge in its stock price, opening nearly 5% higher today. This increase comes following impressive results from Avidity’s AOC 1020 clinical trial...

RNA : 24.11 (-2.78%)
Chart of the Day: Avidity Biosciences --- Something's Up???

Author's Note: Every once in a while I see a stock where most analysts predict decreasing Revenue and Earnings but they all seem to recommend it anyway — Here is a good example. Please tell my what...

RNA : 24.11 (-2.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the...

See More

Key Turning Points

3rd Resistance Point 25.96
2nd Resistance Point 25.22
1st Resistance Point 24.67
Last Price 24.11
1st Support Level 23.38
2nd Support Level 22.64
3rd Support Level 22.09

See More

52-Week High 56.00
Fibonacci 61.8% 42.82
Fibonacci 50% 38.76
Fibonacci 38.2% 34.69
Last Price 24.11
52-Week Low 21.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar